Search
for
Sort by
Research 91–120 of 730
- UP-02.010 Urinary PSA: Marker of Benign Prostatic Hyperplasia?
- The Percentage of Free PSA and Urinary Markers Distinguish Prostate Cancer from Benign Hyperplasia and Contribute to a More Accurate Indication for Prostate Biopsy
- Prostate Specific Antigen Levels in Diabetic and Non-Diabetic Men from the 2001–2002 National Health and Nutrition Examination Survey
- Finasteride-its impact on sexual function and prostate cancer
- Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis
- Abiraterone and spironolactone in prostate cancer: a combination to avoid
- Prostate-Specific Antigen as a Marker of Hyperandrogenism in Women and Its Implications for Antidoping
- Three Considerations Before Advising 5-α-Reductase Inhibitors for Chemoprevention
- Hormonal treatment for male-pattern hair loss: implications for cancer of the prostate?
- Hydroxychloroquine modulates the progression of experimentally induced benign prostatic hyperplasia in rats via targeting EGFR/ERK/STAT3 and AR/FOXO1/TRAIL pathways: computational and in vivo studies
- Antiandrogenic activity of Riboflavin 5′-phosphate (FMN) in 22Rv1 and LNCaP human prostate cancer cell lines
- Étude PCPT : les biais attendus et leur gestion
- Editorial comment
- A Chance Finding of High Grade Prostate Cancer in a 35-Year-Old Male – A Case Report and Outcomes of Robotic Radical Prostatectomy in Young Men with Prostate Cancer
- S5 IS THE RADICAL PROSTATECTOMY THE BEST CHOICE FOR PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER?
- NEURONAL MIMICRY AS A RESISTANCE PHENOTYPE IN CANCER CELLS
- Finasteride: The First 5α-Reductase Inhibitor
- 피나스테라이드의 특성에 대한 이론적 연구
- Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial
- Ganoderma lucidum is an inhibitor of testosterone-induced prostatic hyperplasia in rats
- Benign prostatic hyperplasia and male lower urinary symptoms: A guide for family physicians
- Preventive Effects of Monascus on Androgen-Related Diseases: Androgenetic Alopecia, Benign Prostatic Hyperplasia, and Prostate Cancer
- Economic Issues in the Treatment of BPH
- Alcohol and Prostate Cancer: Time to Draw Conclusions
- Administration of Caesalpinia bonduc Seed Extracts Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia (BPH) in Male Wistar Rats
- Inhibitory effects of TripTripterygium wilfordii multiglycoside on benign prostatic hyperplasia in rats
- Finasteride: Middle-Age Cure-All for Alopecia and Benign Prostatic Hyperplasia?–Reply–II
- Comparison of combination therapy with tamsulosin and dutasteride or finasteride in patients with benign prostatic hyperplasia: a randomized clinical trial
- Hepatoprotective and anti-hyperplastic effects of silver nanoparticles biosynthesised using aqueous extracts of <i>M. scaber</i> : Insights from acetaminophen and testosterone experimental models
- Protective role of agomelatine via modulation of TLR4/NF-κB: NLRP3/IL-1β signaling pathways in testosterone-induced benign prostatic hyperplasia in rats